CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. [electronic resource]
Producer: 20160502Description: 211-22 p. digitalISSN:- 1533-4406
- Analysis of Variance
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- genetics
- CDX2 Transcription Factor
- Chemotherapy, Adjuvant
- Colonic Neoplasms -- drug therapy
- Computational Biology
- Databases, Genetic
- Disease-Free Survival
- Female
- Gene Expression
- Homeodomain Proteins -- genetics
- Humans
- Male
- Neoplasm Staging
- Oligonucleotide Array Sequence Analysis
- Prognosis
- RNA, Messenger -- metabolism
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.